iifl-logo-icon 1

Saroja Pharma Industries India Ltd Share Price

42.7
(0.00%)
Jul 22, 2024|10:41:46 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open42.7
  • Day's High42.7
  • 52 Wk High82.9
  • Prev. Close42.7
  • Day's Low42.7
  • 52 Wk Low33.1
  • Turnover (lac)2.73
  • P/E19.59
  • Face Value10
  • Book Value0
  • EPS2.18
  • Mkt. Cap (Cr.)17.17
  • Div. Yield0
No Records Found

Saroja Pharma Industries India Ltd KEY RATIOS

Sector

Trading

Open

42.7

Prev. Close

42.7

Turnover(Lac.)

2.73

Day's High

42.7

Day's Low

42.7

52 Week's High

82.9

52 Week's Low

33.1

Book Value

0

Face Value

10

Mkt Cap (₹ Cr.)

17.17

P/E

19.59

EPS

2.18

Divi. Yield

0

Saroja Pharma Industries India Ltd Corporate Action

21 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Saroja Pharma Industries India Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Saroja Pharma Industries India Ltd SHAREHOLDING SNAPSHOT

22 Jul, 2024|11:11 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 73.01%

Foreign: 0.00%

Indian: 73.01%

Non-Promoter- 26.98%

Institutions: 0.00%

Non-Institutions: 26.98%

Custodian: 0.00%

Share Price

Saroja Pharma Industries India Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021

Equity Capital

2.94

0.23

0.01

Preference Capital

0

0

0

Reserves

2.15

3.8

0.93

Net Worth

5.09

4.03

0.94

Minority Interest

View Balance Sheet
Loading...

No Record found

View Profit & Loss
Loading...

No Record found

View Cash Flow
Loading...

No Record found

View Ratios

No Record found

Saroja Pharma Industries India Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Adani Enterprises Ltd

ADANIENT

3,005.7

122.73,42,690.04776.710.049,210.18145.96

Aegis Logistics Ltd

AEGISLOG

854.4

73.8829,977.16125.880.38721.5167.87

Cello World Ltd

CELLO

940.55

334.8220,781.9718.620.15260.7765.65

Redington Ltd

REDINGTON

199.03

14.9415,541.68160.573.1210,490.2446.35

Honasa Consumer Ltd

HONASA

462.35

123.2814,910.3726.710427.1734.67

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Saroja Pharma Industries India Ltd

Management

Register Office

Registrar Office

No Record Found

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Reports by Saroja Pharma Industries India Ltd

Summary

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of Saroja Pharma Industries India Private Limited on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra. Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to Saroja Pharma Industries India Limited through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name Saroja Pharma Industries India Private Limited. During this time, they focused on building a strong foundation and laying the groundwork for their future growth and success. With dedication and strategic planning, they managed to establish a reputable presence in the pharmaceutical industry.Gradually, as Company expanded and gained momentum, the Promoters made a significant decision to convert their business from a Private Limited to a Public Limited, through which the Company was establish. Thus, transformation opened up new avenues for growth, allowing it to access a wider pool of investors and enhance the overall ma
Read More

Company FAQs

What is the Saroja Pharma Industries India Ltd share price today?

Down Arrow

The Saroja Pharma Industries India Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is Rs.₹42.7 today.

What is the Market Cap of Saroja Pharma Industries India Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Saroja Pharma Industries India Ltd is ₹17.17 Cr. as of 22 Jul ‘24

What is the PE and PB ratio of Saroja Pharma Industries India Ltd?

Down Arrow

The PE and PB ratios of Saroja Pharma Industries India Ltd is 19.59 and 1.17 as of 22 Jul ‘24

What is the 52 Week High and Low of Saroja Pharma Industries India Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Saroja Pharma Industries India Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Saroja Pharma Industries India Ltd is ₹33.1 and ₹82.9 as of 22 Jul ‘24

What is the CAGR of Saroja Pharma Industries India Ltd?

Down Arrow

Saroja Pharma Industries India Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at -37.44%, 6 Month at -15.94%, 3 Month at 1.18% and 1 Month at 1.67%.

What is the shareholding pattern of Saroja Pharma Industries India Ltd?

Down Arrow

The shareholding pattern of Saroja Pharma Industries India Ltd is as follows:
Promoters - 73.02 %
Institutions - 0.00 %
Public - 26.98 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.